Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Jan;113(1):68-74.
doi: 10.1007/s00392-023-02239-8. Epub 2023 Jun 9.

Features and outcomes of bailout repeat transcatheter aortic valve implantation (TAVI): the Bailout Acute TAVI-in-TAVI to Lessen Events (BATTLE) international registry

Affiliations
Multicenter Study

Features and outcomes of bailout repeat transcatheter aortic valve implantation (TAVI): the Bailout Acute TAVI-in-TAVI to Lessen Events (BATTLE) international registry

Arturo Giordano et al. Clin Res Cardiol. 2024 Jan.

Abstract

Aim: Transcatheter aortic valve implantation (TAVI) is a mainstay in the management of severe aortic stenosis in patients with intermediate to prohibitive surgical risk. When a single TAVI device fails and cannot be retrieved, TAVI-in-TAVI must be performed acutely, but outcomes of bailout TAVI-in-TAVI have been incompletely appraised. We aimed at analyzing patient, procedural and outcome features of patients undergoing bailout TAVI-in-TAVI in a multicenter registry.

Methods: Details of patients undergoing bailout TAVI-in-TAVI, performed acutely or within 24 h of index TAVI, in 6 international high-volume institutions, were collected. For every case provided, 2 same-week consecutive controls (prior TAVI, and subsequent TAVI) were provided. Outcomes of interest were procedural and long-term events, including death, myocardial infarction, stroke, access site complication, major bleeding, and reintervention, and their composite (i.e. major adverse events [MAE]).

Results: A total of 106 patients undergoing bailout TAVI-in-TAVI were included, as well as 212 controls, for a total of 318 individuals. Bailout TAVI-in-TAVI was less common in younger patients, those with higher body mass index, or treated with Portico/Navitor or Sapien devices (all p < 0.05). Bailout TAVI-in-TAVI was associated with higher in-hospital rates of death, emergency surgery, MAE, and permanent pacemaker implantation (all p < 0.05). Long-term follow-up showed that bailout TAVI-in-TAVI was associated with higher rates of death and MAE (both < 0.05). Similar findings were obtained at adjusted analyses (all p < 0.05). However, censoring early events, outlook was not significantly different when comparing the two groups (p = 0.897 for death, and p = 0.645 for MAE).

Conclusions: Bail-out TAVI-in-TAVI is associated with significant early and long-term mortality and morbidity. Thus, meticulous preprocedural planning and sophisticated intraprocedural techniques are of paramount importance to avoid these emergency procedures.

Keywords: Aortic stenosis; Bailout; TAVI-in-TAVI; TAVR-in-TAVR; Transcatheter aortic valve implantation; Transcatheter aortic valve replacement.

PubMed Disclaimer

Conflict of interest statement

Giuseppe Biondi-Zoccai has consulted for Amarin, Balmed, Cardionovum, Crannmedical, Endocore Lab, Eukon, Innovheart, Guidotti, Meditrial, Microport, Opsens Medical, Replycare, Teleflex, and Terumo. Azeem Latib has served on Advisory Boards or as a consultant for Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and Philips. Andreas Schaefer received speaker honoraria from Abbott. Andrea Scotti has served as a consultant for NeoChord. All other authors report no conflict of interest.

Figures

Fig. 1
Fig. 1
Summary of inhospital and long-term event rates. MAE major adverse event, TAVI transcatheter aortic valve implantation
Fig. 2
Fig. 2
Failure curves for death and major adverse event, distinguishing events occurring within and after 1 month. TAVI transcatheter aortic valve implantation

Similar articles

Cited by

References

    1. Giordano A, Biondi-Zoccai G, Frati G, editors. Transcatheter aortic valve implantation: clinical, interventional, and surgical perspectives. Cham: Springer Nature Publishing; 2019.
    1. Barbanti M, Buccheri S, Rodés-Cabau J, Gulino S, Généreux P, Pilato G, Dvir D, Picci A, Costa G, Tamburino C, Leon MB, Webb JG. Transcatheter aortic valve replacement with new-generation devices: a systematic review and meta-analysis. Int J Cardiol. 2017;245:83–89. doi: 10.1016/j.ijcard.2017.07.083. - DOI - PubMed
    1. Vrachatis DA, Vavuranakis M, Tsoukala S, Giotaki S, Papaioannou TG, Siasos G, Deftereos G, Giannopoulos G, Raisakis K, Tousoulis D, Deftereos S, Vavuranakis M. TAVI: Valve in valve. A new field for structuralists? Literature review. Hellenic J Cardiol. 2020;61:148–153. doi: 10.1016/j.hjc.2019.10.016. - DOI - PubMed
    1. Gallo M, Fovino LN, Blitzer D, Doulamis IP, Guariento A, Salvador L, Tagliari AP, Ferrari E. Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review. Eur J Cardiothorac Surg. 2022;61:967–976. doi: 10.1093/ejcts/ezab443. - DOI - PubMed
    1. Abdel-Wahab M, Kitamura M, Krieghoff C, Lauten P, Komatsu I, Thiele H, Holzhey D, Dvir D. BASILICA for a degenerated self-expanding transcatheter heart valve: structural considerations for supra-annular prosthetic leaflets. JACC Cardiovasc Interv. 2020;13:778–781. doi: 10.1016/j.jcin.2019.10.008. - DOI - PubMed

Publication types